FDA daily

FDA daily for Wednesday, July 1, 2026

In this issue: 4 shortage updates, 19 approvals, 31 drug recalls, 32 device recalls, 24 device decisions, 108 label changes and 13 food or supplement recalls. 3 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug shortages

FDA date:

FDA updated 4 shortage entries on Tue, Jun 30: 4 new, 4 to be discontinued.

  • Gadoterate Meglumine Injection

    Jiangsu Hengrui Pharmaceuticals Co., Ltd.

    To Be Discontinued65219-080-05Medical Imaging
  • Gadobutrol Injection

    Jiangsu Hengrui Pharmaceuticals Co., Ltd.

    To Be Discontinued65219-281-02Medical Imaging
  • Daptomycin Injection

    Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)

    To Be Discontinued57884-3151-1Anti-Infective
  • Caspofungin Acetate Injection

    Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)

    To Be Discontinued0781-3421-94Anti-Infective
Browse drug shortages in FDA data →

Drug and biologic approvals

FDA date:

On Wed, Jun 24 FDA approved 3 new applications (1 brand or biologic, 2 generic) and 16 supplements to existing ones.

Browse drug and biologic approvals in FDA data →

Drug recalls

FDA date:

FDA's enforcement report dated Wed, Jun 24 lists 31 drug recalls: 30 Class II, 1 Class III.

Browse drug recalls in FDA data →

Device recalls

FDA date:

FDA posted 32 device recalls from 9 firms on Wed, Jun 24.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 17 510(k)s and 7 PMA decisions on Wed, Jun 17.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

108 drug labels took effect on Wed, Jun 17. Below: those, and labels carrying a boxed warning.

  • Capecitabine

    CAPECITABINE · Ascend Laboratories, LLC · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Litfulo

    RITLECITINIB · U.S. Pharmaceuticals · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Ticagrelor

    TICAGRELOR · Macleods Pharmaceuticals Limited · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Ticagrelor

    TICAGRELOR · Golden State Medical Supply, Inc. · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Fluoxetine HCL

    FLUOXETINE HCL · Direct_rx · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
Browse label updates in FDA data →

Food and supplement recalls

FDA date:

FDA's enforcement report dated Wed, Jun 24 lists 13 food or supplement recalls: 3 Class I, 9 Class II, 1 Class III.

Browse food and supplement recalls in FDA data →

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.